Categories: Insider Trading News

Tempus AI CEO Eric Lefkofsky sells $7 million in shares


Eric Lefkofsky, CEO and Chairman of Tempus AI, Inc. (NASDAQ:TEM), not too long ago bought shares price roughly $7,045,334, in response to an SEC submitting. The transactions occurred on December 18, 2024, with the sale costs starting from $37.34 to $39.38 per share. The sale comes because the inventory has skilled a major 13% decline over the previous week, in response to InvestingPro information. Following these transactions, Lefkofsky retains important holdings within the firm by way of varied entities, together with Blue Media, LLC and Grey Media, LLC. The gross sales have been made beneath a pre-established buying and selling plan. The $5.2 billion market cap firm presently trades close to its InvestingPro Honest Worth, sustaining a strong liquidity place with a present ratio of two.69 and exhibiting robust income development of 32% year-over-year. InvestingPro subscribers can entry 6 extra key insights about Tempus AI’s monetary well being and market place.

In different current information, Tempus AI has skilled important adjustments in its inventory worth targets following its newest earnings report and strategic acquisition of genetics agency Ambry. Piper Sandler raised its worth goal from $40 to $70, sustaining a Impartial ranking. Stifel downgraded the inventory from Purchase to Maintain, however elevated the worth goal to $65. Needham raised its inventory worth goal to $56, holding its Purchase ranking.

Tempus AI’s acquisition of Ambry Genetics is considered as a key strategic transfer, doubtlessly providing rapid genomics capabilities and future alternatives in information and purposes. The corporate has additionally partnered with Avacta Therapeutics to advance oncology drug growth utilizing AI, granting Avacta entry to Tempus’s complete multimodal datasets.

Additional, Tempus AI’s Tempus ECG-AF machine, which makes use of synthetic intelligence to determine sufferers at larger danger of atrial fibrillation/flutter, not too long ago obtained FDA clearance. These are among the many current developments surrounding Tempus AI.

This text was generated with the help of AI and reviewed by an editor. For extra info see our T&C.

admin

Share
Published by
admin

Recent Posts

Core PCE inflation eases, Capital Economics sees sturdy U.S. financial system

Investing.com -- Capital Economics, a number one financial analysis agency, on Friday reported that the…

8 minutes ago

Volkswagen to chop greater than 35,000 jobs in Germany by 2030

FRANKFURT (Reuters) - Volkswagen (ETR:VOWG_p) on Friday mentioned it had agreed with unions to chop…

23 minutes ago

tharimmune CEO Randy Milby buys shares value $9,752

Tharimmune, Inc. (NASDAQ:THAR) CEO Randy Milby has just lately elevated his stake within the firm…

38 minutes ago

Fed’s Hammack says financial energy argued towards price lower

By Michael S. Derby NEW YORK (Reuters) -Federal Reserve Financial institution of Cleveland President Beth…

58 minutes ago

Stellantis reverses Ohio layoffs weeks after CEO’s abrupt departure

(Reuters) -Stellantis has reversed its resolution to put off about 1,100 staff at an Ohio…

1 hour ago

EOS Falls 10% In Bearish Commerce

Investing.com - EOS was buying and selling at $0.7666 by 00:09 (05:09 GMT) on the…

1 hour ago